Juliana F. Gregorio
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oral or intranasal angiotensin-(1-7) improves anxiety and depression-like behaviors in mice subjected to allergic pulmonary inflammation.
Journal: Behavioural brain research
Published: March 31, 2025
A single dose of angiotensin-(1-7) resolves eosinophilic inflammation and protects the lungs from a secondary inflammatory challenge.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: December 16, 2023
Angiotensin-(1-7)/Mas receptor modulates anti-inflammatory effects of exercise training in a model of chronic allergic lung inflammation.
Journal: Life sciences
Published: April 06, 2021
Asthma: role of the angiotensin-(1-7)/Mas (MAS1) pathway in pathophysiology and therapy.
Journal: British journal of pharmacology
Published: March 31, 2021
Treatment with inhaled formulation of angiotensin-(1-7) reverses inflammation and pulmonary remodeling in a model of chronic asthma.
Journal: Immunobiology
Published: February 05, 2020
Oral formulation angiotensin-(1-7) therapy attenuates pulmonary and systemic damage in mice with emphysema induced by elastase.
Journal: Immunobiology
Published: June 26, 2019
Angiotensin-(1-7) Promotes Resolution of Eosinophilic Inflammation in an Experimental Model of Asthma.
Journal: Frontiers in immunology
Published: November 06, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026